Where does Revvity Health Sciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Revvity Health Sciences, Inc. ranks #23,293 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Revvity Health Sciences, Inc. hold?

Revvity Health Sciences, Inc. holds 12 US utility patents granted between 2023 and 2025, spanning 15 technology areas.

What is Revvity Health Sciences, Inc.'s Innovation Score?

Revvity Health Sciences, Inc. has an Innovation Score of 54.8 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Revvity Health Sciences, Inc. focus on?

Revvity Health Sciences, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 8 patents, ranking #1,791 of 7,863 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Revvity Health Sciences, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Revvity Health Sciences, Inc..

What does claim depth mean for Revvity Health Sciences, Inc.'s patents?

Revvity Health Sciences, Inc.'s patents average 20.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Revvity Health Sciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Revvity Health Sciences, Inc.

USPTO PatentsView assignee record - 12 granted patents across 15 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Revvity ranks #23,293 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 15 technology areas.

#23,293
of 49,997 US assignees by volume: Top 7%
by Innovation Score (54.8/100): 20.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23293 · US Corporation #23,293 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #23,293/49,997
PHOTO-FINISH Research Now Group
CPC-FOCUS G01N · 15 areas
INNOV-PAR 54.8/100
CLAIMS-DENSE 20.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Research Now Group, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Revvity’s 54.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (16%) Velocity 20.0 pts (36%) Breadth 13.7 pts (25%) Claim depth 12.3 pts (22%)

Qualcomm Incorporated · highest

85
Revvity Health… · this assignee

55
3D Lighting… · lowest

7

What this shows Revvity's Innovation Score is 54.8/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Revvity?

Each dot is one of Revvity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Revvity’s own 20.4 claims/patent is ABOVE the 19.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Revvity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Revvity's grants concentrate

Revvity Health Sciences, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 66.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2023. By volume, Revvity sits between Research Now Group, LLC and Right90, Inc..

Revvity's three-year grant acceleration

Revvity Health Sciences, Inc. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Research Now Group

12
Respira Therapeut…

12
Response

12
Resverlogix

12
Rexnord Flattop E…

12
Rhythm Watch

12
Riboscience

12
Right90

12
Revvity Health Sc… ◀

12

What this shows Revvity holds 12 patents at rank #23,299, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Revvity

By rank, the assignees closest to #23,299 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Revvity's primary technology class.

Revvity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Revvity Health Sciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	1	8.3%
2024	2	16.7%
2025partial year	9	75.0%

Which technologies does Revvity Health Sciences, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01T - Measurement OF Nuclear OR X-radiation 2

B01D - Separation 1

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 1

A61B - DIAGNOSIS; SURGERY; Identification 1

G06T - Image Data Processing OR Generation, IN General 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07C - Acyclic OR Carbocyclic Compounds 1

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 1

G02B - Optical Elements, Systems OR Apparatus 1

G03B - Apparatus OR Arrangements FOR Taking Photographs OR FOR Projecting OR Viewing THEM; Apparatus OR Arrangements Employing Analogous Techniques Using Waves Other Than Optical WAVES; Accessories Therefor 1

G01B - Measuring Length, Thickness OR Similar Linear DIMENSIONS; Measuring ANGLES; Measuring AREAS; Measuring Irregularities OF Surfaces OR Contours 1

H04N - Pictorial Communication, e.g. Television 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Revvity Health Sciences, Inc.'s patent record in context - here's where to go next.

Revvity Health Sciences, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 66.7% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #23,293 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Revvity Health Sciences, Inc. against Research Now Group, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 54.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.